Search for a Transmissible Agent in Alzheimer’s Disease: Studies of Human Buffy Coat

  • E. E. Manuelidis
  • L. Manuelidis
Part of the Current Topics in Microbiology and Immunology book series (CT MICROBIOLOGY, volume 172)

Abstract

The etiology of Alzheimer’s disease (AD) is totally unknown, despite the vigorous efforts in several laboratories during recent years to solve this mystery. The lack of success in delineating one or more underlying etiologies for AD may be due to the fact that there are no animal models directly derived from this disease. Further, almost all investigative studies of AD concentrate on end stages of disease where fully developed lesions are apparent. In searching for potential etiologies of AD, such fully developed cases might represent the wrong end of the disease spectrum and be relatively uninformative with respect to original inciting events (E.E. Manuelidis 1985). In autopsy brains of individuals with AD, there is clear evidence of a neuronal cemetery, with neuronal devastation and gliosis in selected brain regions. Tangles and more widespread plaques and amyloid deposits are the remaining skeletons and bushes associated with end stage neuronal degeneration. We have postulated that these very important cardinal lesions are the end result rather than the originating causes of AD. Although these sequelae and their associated biochemical processes may play a role in the progression of AD, the initial inciting events are not known. Without underestimating the value of the data generated by our colleagues on the biochemistry and histology of these lesions, we concentrate, rightly or wrongly, on the concept that a transmissible agent may underlie AD during very early stages of disease.

Keywords

Dementia Rabies Scrapie 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Akowitz A, Sklaviadis T, Manuelidis EE, Manuelidis L (1990) Nuclease resistant polyadenylated RNAs of significant size are detected by PCR in highly purified Creutzfeldt-Jakob disease preparations. Microb Pathog 9: 33–45PubMedCrossRefGoogle Scholar
  2. Diringer H (1984) Sustained viremia in experimental hamster scrapie. Arch Virol 82: 105–109PubMedCrossRefGoogle Scholar
  3. Goudsmit J, Morrow CH, Asher DM, Yanagihera RT, Masters CL, Gibbs CJ Jr, Gajdusek DC (1980) Evidence for and against the transmissibility of Alzheimer’s disease. Neurology 30: 945–950PubMedGoogle Scholar
  4. Johnson RT, Mims CA (1968) Pathogenesis of viral infections of the nervous system. N Engl J Med 278: 23–30, 84–92PubMedCrossRefGoogle Scholar
  5. Kuroda Y, Gibbs CJ Jr, Amyx HL, Gajdusek DC (1983) Creutzfeldt-Jakob disease in mice: persistent viremia and preferential replication of virus in low-density lymphocytes. Infect Immun 41:154–161PubMedGoogle Scholar
  6. Manuelidis EE (1985) Presidential address. Creutzfeldt-Jakob disease. J Neuropathol Exp Neurol 44: 1–17PubMedCrossRefGoogle Scholar
  7. Manuelidis EE, Manuelidis L (1989) Suggested links between different types of dementias: Creutzfeldt-Jakob disease, Alzheimer’s disease and retroviral CNS infections. Alzheimers Dis Relat Disorders 3: 100–109CrossRefGoogle Scholar
  8. Manuelidis EE, Angelo JN, Kim JH, Manuelidis L (1976) Serial propagation of Creutzfeldt-Jakob disease in guinea pigs. Proc Natl Acad Sci USA 73: 223–227PubMedCrossRefGoogle Scholar
  9. Manuelidis EE, Gorgacz EJ, Manuelidis L (1978a) Transmission of Creutzfeldt-Jakob disease with scrapie-like syndromes to mice. Nature 271: 778–779PubMedCrossRefGoogle Scholar
  10. Manuelidis EE, Gorgacz EJ, Manuelidis L (1978b) Interspecies transmission of Creutzfeldt-Jakob disease to Syrian hamsters with reference to clinical syndromes and strains of agent. Proc Natl Acad Sci USA 75: 3432–3436PubMedCrossRefGoogle Scholar
  11. Manuelidis EE, Gorgacz EJ, Manuelidis L (1978c) Viremia in experimental Creutzfeldt-Jakob disease. Science 200: 1069–1071PubMedCrossRefGoogle Scholar
  12. Manuelidis EE, Kim JH, Mericangas JR, Manuelidis L (1985) Transmission of Creutzfeldt-Jakob disease from human blood. Lancet ii: 896–897CrossRefGoogle Scholar
  13. Manuelidis EE, deFigueiredo JM, Kim JH, Fritch WW, Manuelidis, L (1988) Transmission studies from blood of Alzheimer’s disease patients and healthy relatives. Proc Natl Acad Sci USA 85: 4898–4901PubMedCrossRefGoogle Scholar
  14. Manuelidis L, Manuelidis EE (1986) Recent developments in scrapie and Creutzfeldt-Jakob disease. Prog Med Virol 3: 78–98Google Scholar
  15. Manuelidis L, Manuelidis EE (1989) Creutzfeldt-Jakob disease and dementias. Microb Pathog 7: 157–164PubMedCrossRefGoogle Scholar
  16. Murdoch G, Sklaviadis T, Manuelidis EE, Manuelidis L (1990) Potential retroviral RNA transcripts in infectious fractions of Creutzfeldt-Jakob disease. J Virol 64: 1477–1486PubMedGoogle Scholar
  17. Sklaviadis T, Manuelidis L, Manuelidis EE (1989) Physical properties of the Creutzfeldt-Jakob disease agent. J Virol 63: 1212–1222PubMedGoogle Scholar
  18. Sklaviadis T, Akowitz A, Manuelidis EE, Manuelidis L (1990) Nuclease treatment results in high specific purification of Creutzfeldt-Jakob disease infectivity with a density characteristic of nucleic acid-protein complex. Arch Virol 112: 215–228PubMedCrossRefGoogle Scholar
  19. Tateishi J, Sato Y, Koga M, Doi H, Ohta M (1980) Experimental transmission of human subacute spongiform encephalopathies to small rodents. 1. Clinical and histological observations. Acta Neuropathol 51: 127–134PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 1991

Authors and Affiliations

  • E. E. Manuelidis
    • 1
  • L. Manuelidis
    • 1
  1. 1.Section of NeuropathologyYale University School of MedicineNew HavenUSA

Personalised recommendations